مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

235
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

161
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Sumatriptan ameliorates renal injury induced by cisplatin in mice

Pages

  563-567

Abstract

 Objective(s): Cisplatin (Cis) is an anticancer compound, which is used for the treatment of various cancers. Sumatriptan (Suma) is a selective agonist of 5-hydroxytryptamine 1B/1D (5HT1B/1D) receptor, which is prescribed for the management of migraine. It is well-established that Suma has anti-inflammatory and antioxidant properties. We have explored the protective effects of Suma in the mitigation of Cis-induced Nephrotoxicity. Materials and Methods: The Mice received a single IP injection of Cis (20 mg/kg) on the first day of the experiment. Suma treatment (0. 1 and 0. 3 mg/kg/day, IP) was started on day 1 and continued for 3 consecutive days. Results: Creatinine (Cr), blood urea nitrogen (BUN) and malondialdehyde (MDA) levels were elevated and glutathione peroxidase (GPx) as well as superoxide dismutase (SOD) activities were decreased in Cis-treated Mice. Suma (more potently 0. 3 mg/kg) reduced Cr, BUN and MDA levels and increased SOD and GPx levels. Suma also reduced the acute renal injury (tubular degeneration, tubular cells vacuolation, tubular necrosis and cast), which corresponded to kidney damage in Cis-treated Mice. Conclusion: These findings demonstrate that Suma mitigates Cis-induced renal injury by inhibition of Oxidative stress and enhancing the antioxidant enzymes activities.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Bazmandegan, Gholamreza, Amirteimoury, Morteza, KAEIDI, AYAT, SHAMSIZADEH, ALI, Khademalhosseini, Morteza, NEMATOLLAHI, MOHAMMAD HADI, HASSANIPOUR, MAHSA, & FATEMI, IMAN. (2019). Sumatriptan ameliorates renal injury induced by cisplatin in mice. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 22(5), 563-567. SID. https://sid.ir/paper/722347/en

    Vancouver: Copy

    Bazmandegan Gholamreza, Amirteimoury Morteza, KAEIDI AYAT, SHAMSIZADEH ALI, Khademalhosseini Morteza, NEMATOLLAHI MOHAMMAD HADI, HASSANIPOUR MAHSA, FATEMI IMAN. Sumatriptan ameliorates renal injury induced by cisplatin in mice. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2019;22(5):563-567. Available from: https://sid.ir/paper/722347/en

    IEEE: Copy

    Gholamreza Bazmandegan, Morteza Amirteimoury, AYAT KAEIDI, ALI SHAMSIZADEH, Morteza Khademalhosseini, MOHAMMAD HADI NEMATOLLAHI, MAHSA HASSANIPOUR, and IMAN FATEMI, “Sumatriptan ameliorates renal injury induced by cisplatin in mice,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 22, no. 5, pp. 563–567, 2019, [Online]. Available: https://sid.ir/paper/722347/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button